Cargando…
Macrophages as a Potential Immunotherapeutic Target in Solid Cancers
The revolution in cancer immunotherapy over the last few decades has resulted in a paradigm shift in the clinical care of cancer. Most of the cancer immunotherapeutic regimens approved so far have relied on modulating the adaptive immune system. In recent years, strategies and approaches targeting t...
Autores principales: | Mishra, Alok K., Banday, Shahid, Bharadwaj, Ravi, Ali, Amjad, Rashid, Romana, Kulshreshtha, Ankur, Malonia, Sunil K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863216/ https://www.ncbi.nlm.nih.gov/pubmed/36679900 http://dx.doi.org/10.3390/vaccines11010055 |
Ejemplares similares
-
Emerging Trends in Immunotherapy for Cancer
por: Mishra, Alok K., et al.
Publicado: (2022) -
Next-Generation Sequencing Technology: Current Trends and Advancements
por: Satam, Heena, et al.
Publicado: (2023) -
Mesothelin: An Immunotherapeutic Target beyond Solid Tumors
por: Faust, Joshua R., et al.
Publicado: (2022) -
FBXL20 promotes breast cancer malignancy by inhibiting apoptosis through degradation of PUMA and BAX
por: Manne, Rajesh Kumar, et al.
Publicado: (2021) -
Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors
por: Ortiz, Michael V., et al.
Publicado: (2019)